← Leaderboards
Jane L Liesveld
University Of Rochester
$1,720,822
Attributed
$2,517,754
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $534.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,517,754 · 3
By mechanism
R01$1,593,864 · 1
R21$923,890 · 2
Top collaborators
- Laura Maria Calvi3 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Roman Eliseev$4,978,051
- Sanjay B. Maggirwar$21,478,048
- Jane M Sottile$4,464,720
- Philip A Knauf$1,763,081
- Kathleen Ann Lamkin-Kennard$288,834
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsReportingCellsInterestMarrowPlayLeukemiaDnmt3aDisabilityDysmyelopoietic SyndromesDefined ContributionDerepressionAgedDna RepairChronicAreaClinical DevelopmentBone Marrow FailureAge RelatedCell ModelAgingBiology Of AgingAccelerationCardiovascular Risk Factor
Grant awards (7)
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis$524,156
R01 · FY2025 · AG
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis$534,854
R01 · FY2024 · AG
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis$534,854
R01 · FY2023 · AG
Substrata Interactions of Normal and Leukemic Hematopoietic Stem Cells$173,250
R21 · FY2009 · CA · contact PI
Substrata Interactions of Normal and Leukemic Hematopoietic Stem Cells$207,900
R21 · FY2008 · CA · contact PI
Proteasome Inhibition in Myelodysplastic Syndromes$268,104
R21 · FY2006 · CA · contact PI
Proteasome Inhibition in Myelodysplastic Syndromes$274,636
R21 · FY2005 · CA